Table 3.

Changes in T-cell proliferative responses to GPIIb/IIIa and tetanus toxoid after a single injection of IDEC-131/E6040



Stimulation index of antigen-specific T-cell proliferation
IDEC-131/E6040 dose
Day 0 pretreatment
Day 7 after treatment
Day 42 after treatment
GPIIb/IIIa-specific T-cell response    
    2 mg/kg   2.3 ± 0.8   2.6 ± 1.5   2.2 ± 1.5  
    5 mg/kg   6.5 ± 4.9   4.6 ± 4.1   2.3 ± 1.2  
    10 mg/kg   8.3 ± 5.9   4.7 ± 5.1*  3.2 ± 1.0 
Tetanus toxoid-specific T-cell response    
    2 mg/kg   4.9 ± 2.0   5.0 ± 3.3   3.3 ± 1.9  
    5 mg/kg   1.9 ± 1.6   1.9 ± 1.5   2.6 ± 2.6  
    10 mg/kg
 
4.5 ± 3.2
 
4.0 ± 2.6
 
3.5 ± 1.8
 


Stimulation index of antigen-specific T-cell proliferation
IDEC-131/E6040 dose
Day 0 pretreatment
Day 7 after treatment
Day 42 after treatment
GPIIb/IIIa-specific T-cell response    
    2 mg/kg   2.3 ± 0.8   2.6 ± 1.5   2.2 ± 1.5  
    5 mg/kg   6.5 ± 4.9   4.6 ± 4.1   2.3 ± 1.2  
    10 mg/kg   8.3 ± 5.9   4.7 ± 5.1*  3.2 ± 1.0 
Tetanus toxoid-specific T-cell response    
    2 mg/kg   4.9 ± 2.0   5.0 ± 3.3   3.3 ± 1.9  
    5 mg/kg   1.9 ± 1.6   1.9 ± 1.5   2.6 ± 2.6  
    10 mg/kg
 
4.5 ± 3.2
 
4.0 ± 2.6
 
3.5 ± 1.8
 
*

P = .054 compared with pretreatment by repeated measures analysis of variance.

P = .08 compared with pretreatment by repeated measures analysis of variance.

Close Modal

or Create an Account

Close Modal
Close Modal